Completed PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT00713167

The Efficacy of Red Grape Seed Extract on Lipid Profile and Oxidized Low-Density Lipoprotein (OX-LDL) (GSE)

Randomized, Cross-Over, Double Blind, Placebo-Controlled Study of Grape Seed Extract in Treating Patients With Mild Hyperlipidemia

Sponsor: Shahid Beheshti University of Medical Sciences

Conditions Hyperlipidemia

Interventions Grape Seed Extract (Vitagrape) Placebo of Grape Seed Extract

Updated 7 times since 2017 Last updated: May 20, 2009 Started: Jul 31, 2008 Primary completion: Dec 31, 2008 Completion: Feb 28, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2/PHASE3 clinical study on Hyperlipidemia, this trial is completed. The trial is conducted by Shahid Beheshti University of Medical Sciences and has accumulated 7 data snapshots since 2008. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Jan 2026 — Present [monthly]

Completed PHASE2/PHASE3
Sep 2025 — Present [monthly]

Completed PHASE2/PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2/PHASE3

Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2_PHASE3

▶ Show 2 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE2_PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2_PHASE3

First recorded

Jul 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Shahid Beheshti University of Medical Sciences
Tabriz University

Data source: Shahid Beheshti University of Medical Sciences

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Tabriz, Iran
• Tehran, Iran